Cost-minimization analysis of using tumor cell-free DNA as monitoring tool in cancer immunotherapy.

6642Background: Albeit showing great benefit in individual cancer patients, only the minority of patients benefit from checkpoint inhibitor immunotherapies (IMTs). Mutation load and PD-L1 staining ...